Protecting a new generation against HPV: Are we willing to be bold?

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 9, 2014, Pages 2559-2561

  Vanderpool, Robin C ^a   Crosby, Richard A ^a   Stradtman, Lindsay R ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

Alternative settings; Emergency departments; HPV vaccination; Missed clinical appointments; Physicians; Policy

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; EMERGENCY HEALTH SERVICE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; INFECTION CONTROL; MEDICATION THERAPY MANAGEMENT; MORTALITY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROCESS OPTIMIZATION; PROGRAM EVALUATION; UNITED STATES; VACCINATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HOSPITAL EMERGENCY SERVICE; PHYSICIAN; PROCEDURES; UTERINE CERVICAL NEOPLASMS; UTILIZATION;

ATTITUDE OF HEALTH PERSONNEL; DELIVERY OF HEALTH CARE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; PAPILLOMAVIRUS VACCINES; PHYSICIANS; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84920113586     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/21645515.2014.970068     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention (US). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59(20):626-9.
2. National Cancer Institute (US). Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President's Cancer Panel. Bethesda, MD: National Cancer Institute; 2014.
3. Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014 -United States. MMWR Morb Mortal Wkly Rep 2014;63:620-4; PMID:25055185
4. Vanderpool RC, Cohen EL, Crosby RA, Jones MG, Bates W, Casey BR, Collins T. "1-2-3 Pap" intervention improves HPV vaccine series completion among Appalachian women. J Commun 2013; 63:95-115; http://dx.doi.org/10.1111/jcom.12001
5. Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines 2014; 13:235-46; PMID:24405401; http://dx.doi.org/10.1586/14760584.2013.871204
6. Hill M, Okugo G. Emergency medicine physician attitudes towards HPV vaccine uptake in an emergency dpeartment setting. Hum Vaccin Immunother 2014;10(9); http://dx.doi.org/10.4161/hv.29634
7. Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health 2014;14:700; PMID:25004868; http://dx.doi.org/10.1186/1471-2458-14-700
8. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014; 168:76-82; http://dx.doi.org/10.1001/jamapediatrics.2013.2752
9. Dempsey A, Cohn L, Dalton V, Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011; 29:528-34; http://dx.doi.org/10.1016/j.vaccine.2010.10.051
10. Centers for Disease Control and Prevention (US). Human Papillomavirus (HPV): what is HPV? [Internet]. Atlanta: Centers for Disease Control and Prevention; [updated 2013 Feb 5; cited 2014 Jul 28]. Available from: www.cdc.govhpvwhatishpv.html"
11. Rysavy MB, Kresowik JD, Liu D, Mains L, Lessard M, Ryan GL. Human papillomavirus vaccination and sexual behavior in young women. J Pediatr Adolesc Gynecol 2014; 27:67-71; http://dx.doi.org/10.1016/j.jpag.2013.08.009
12. Mayhew A, Mullins TL, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA. Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics 2014; 133:404-11; http://dx.doi.org/10.1542/peds.2013-2822
13. Herbert N, Painter JE, Sales JM, Morfaw C, Rask K, Murray D, Diclemente R, Hughes J, Gargano LM. Clarification of "Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines." Hum Vaccin Immunother 2014; 10(9): [Epub ahead of print]; http://dx.doi.org/10.4161/hv.28625
14. McRee AL, Reiter PL, Pepper JK, Brewer NT. Correlates of comfort with alternative settings for HPV vaccine delivery. Hum Vaccin Immunother 2013; 9:306-13; PMID:23291948; http://dx.doi.org/10.4161/hv.22614
15. Australia Government Department of Health. HPV school vaccination program [Internet]. Canberra (AU): Australia Government Department of Health; [updated 2014 Jul 8; cited 2014 Jul 28]. Available from: http: hpv.health.gov.au
16. National Health Service (GB). Childhood vaccines timeline [Internet]. London (GB): National Health Service; [cited 2014 Jul 29]. Available from: http: www.nhs.ukConditionsvaccinationsPageschildhood-vaccination-schedule.aspx